Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-07-12 @ 4:40 AM
Study NCT ID:
NCT04948034
Status:
UNKNOWN
Last Update Posted:
2021-08-27
First Post:
2021-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
Sponsor:
Fudan University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Colorectal Cancer | View |
Keywords: